U.S. Capital Wealth Advisors, LLC Astrazeneca PLC Transaction History
U.S. Capital Wealth Advisors, LLC
- $2.46 Billion
- Q2 2024
A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 4,832 shares of AZN stock, worth $375,059. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,832
Previous 4,613
4.75%
Holding current value
$375,059
Previous $312,000
20.51%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.04 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.31 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.15 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.85 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.37 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $241B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...